FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending May 2010
 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

 

                                                     BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Share Option Plan - Ordinary Shares
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
5,027,516
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
1,831,905
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
3,195,611


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
 


 
 
 
                                                   BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Share Option Plan - ADS
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
6,025,776
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
841,634
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
5,184,142


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000




 
 
 
                                                      BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Wellcome UK Share Option Scheme
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
5,119,750
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
5,119,750


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 


 
 
 
                                                 BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Wellcome International Share Option Scheme
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
13,267,156
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
13,267,156


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 


 
 
 
 
                                               BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Wellcome 1999 Share Option Plan
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
1,040,000
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
1,040,000


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
 

 
 
 
                                                 BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
163,606
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
163,606


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
 
 

 
 
 
                                                     BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
275,420
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
275,420


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 


 
 
 
                                                         BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
100,000
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
100,000


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 

 
 
 
                                                    BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an
ris
.
 
Date:
10 May 2010
 

Name of
applicant
:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Savings Related Share Option Scheme
Period of return:
From:
1 November 2009
To:
30 April 2010
Balance of unallotted securities under scheme(s) from previous return:
5,191,246
Plus: 
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: 
Number of
securities
issued/allotted under scheme(s) during period (see LR3.5.7G):
731,368
Equals: 
Balance under scheme(s) not yet issued/allotted at end of period:
4,459,878


 

Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 

 

 

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date: May 10, 2010

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc